Heather Anspach Email & Phone Number

Clarence Center, Ny, Us

Upstate Ny

Work strategically with academic and community practices, which include oncologists, surgeons, radiation oncologists, genetic counselors, and pathologist to develop customized protocols to identify and test appropriate high risk patients for hereditary cancer syndromes. Chosen multiple times for Director Circle Counsel, mentored new hires, MVP in phase 2 and phase 3 training, area MVP, 4 time area achievement winner, and President Club winner.

Neuroscience representative responsible for sales of anti-epileptic drug to neurologists and psychiatrists, providing patient support for educational and managed care issues.Selected as Regional Sales Instructor to train and mentor new hires, gaining monetary recognition for efforts.Chosen to present at national and regional meetings to demonstrate product data and best sales practices.Developed strategic business plan and utilization of budget to increase product share on 25-year-old drug, currently performing at 129.6% quota accomplishment and ranking 1st in district, 3rd in region and top 10% of nation. Disease state profiling for launch of new pain medication to plastic surgeons, orthopedic surgeons, general surgeons, pain specialist, and anesthesiologists.

Hospital representative for sales of GPIIbIIIa receptor agent to cardiac catherization labs, emergency rooms, ICU/CCU, step down units and pharmacy, responsibilities included establishing acute coronary syndrome pathways, in-servicing multiple departments and providing support to patient care areas administering Integrilin.Coordinated efforts to establish protocol for Health Care System by partnering with physicians and nurses to follow ACH/AHA guidelines providing best care possible for high risk acute coronary syndrome patients.Developed and delivered presentations designed to interpret and communicate competitive data for regional and national meetings.Increased product share from 94% to 97%. Finished 104% to goal, ranked 2nd in region and top 25% of the nation.

Responsible for sales of novel sedation agent and a unique anti-hypertensive agent to intensive care units, surgery (general, vascular and cardiothoracic), anesthesia, intensivist, interventional cardiology, interventional radiology, nephrology and pharmacy in Western NY area."Quota buster" for Corlopam sales in 2002, growing business 1160% from previous year and ranking 8 of 108 for Corlopam sales growth and 22 of 108 for Precedex sales.Spearheaded development of one account to become Center of Excellence for training other hospitals in the country to use novel sedation agent.Launched Urokinase, thromboyltic agent, back into the medical community, which included interventional cardiology, interventional radiology, endovascular surgeons, pulmonologist, hematology, dialysis, pharmacy and all support personnel.Achieved a 100% to goal for the reintroduction of Urokinase.

Territory management of 2-3 million dollar market. Responsible for sales of antidepressant and diabetic agents to endocrinologist, hospitals, clinics and primary care market in Rochester NY.

Performed in vitro and in vivo experimental studies utilizing a multidisciplinary approach to central nervous system drug discovery.Quantified neurochemical parameters and applied biochemical techniques to support pharmacological studies.Researched and statistically analyze data, performing literature searches updating and maintain database.

Oncology Defined characterization of novel protein associated with breast cancer by performing biochemical and molecular techniques.Organized the set up of new laboratory, responsible for chemical inventory, purchasing supplies and composing protocol manuals.

Master Of Arts, Biochemistry

Worked in the area of breast cancer research. My master's thesis involved the characterization of a novel protein nmt55.

Mba Courses

Bachelor Of Science, Biochemistry

Laboratory assistant in a Biochemistry a Laboratory for 3.5 years.